Moleculin Biotech (MBRX) Stock Chart & Stock Price History → The #1 Biotech Stock to Watch in 2024 is Attacking Viruses in a Unique Way (From Smallcaps Daily) (Ad) Free MBRX Stock Alerts $5.03 +0.11 (+2.24%) (As of 04:27 PM ET) Add Compare Share Share ChartStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media Moleculin Biotech Stock Price Performance5 Day Performance+5.67%1 Month Performance+16.17%3 Month Performance-32.60%6 Month Performance-45.12%Year-To-Date Performance-60.94%1 Year Performance-45.12% Receive MBRX Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Moleculin Biotech and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Banyan Hill PublishingThe Best AI Stock to Own in the World Today is Trading for Just $25“Titan of Tech” Bets Big on Tiny AI Company He’s made as much as 3,250,000% in just three years on companies like Facebook, Airbnb, and PayPal… But our research shows his latest investment could be his most successful venture yet.See how you can invest alongside him MBRX Stock Chart for Thursday, May, 16, 2024 MBRX Chart by TradingView Moleculin Biotech Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/15/2024$4.85$4.92+1.44%$5.15$4.9012,352 shs$11.37 million05/14/2024$4.67$4.85+3.85%$4.88$4.5233,920 shs$10.80 million05/13/2024$4.76$4.67-1.89%$4.90$4.6213,086 shs$10.41 million05/10/2024$4.84$4.76-1.65%$5.29$4.6132,288 shs$10.60 million05/09/2024$4.91$4.84-1.43%$5.05$4.6120,212 shs$10.78 million05/08/2024$5.09$4.91-3.54%$5.32$4.7057,703 shs$10.95 million Get the Latest News and Ratings for MBRX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Moleculin Biotech and its competitors with MarketBeat's FREE daily newsletter. 05/07/2024$5.04$5.09+0.99%$5.44$4.85101,187 shs$11.35 million05/06/2024$5.02$5.04+0.40%$5.40$5.0430,333 shs$11.24 million05/03/2024$5.13$5.02-2.14%$5.41$5.0016,521 shs$11.20 million05/02/2024$4.96$5.13+3.43%$5.36$5.065,669 shs$11.44 million05/01/2024$5.02$4.96-1.20%$5.47$4.9629,417 shs$11.06 million04/30/2024$5.01$5.02+0.20%$5.24$4.9218,259 shs$11.20 million04/29/2024$4.63$5.01+8.21%$5.25$4.8046,180 shs$11.17 million04/26/2024$4.31$4.77+10.72%$4.90$4.4123,988 shs$10.64 million04/25/2024$4.35$4.31-0.96%$4.50$4.2822,596 shs$9.61 million04/24/2024$4.60$4.35-5.43%$4.62$4.357,365 shs$9.69 million04/23/2024$4.30$4.60+6.98%$4.60$4.297,427 shs$10.26 million04/22/2024$4.65$4.30-7.53%$4.78$4.3016,716 shs$9.59 million04/19/2024$4.54$4.65+2.42%$4.66$4.4010,562 shs$10.37 million04/18/2024$4.28$4.54+6.07%$5.00$4.4149,637 shs$10.12 million04/17/2024$4.33$4.28-1.15%$4.42$4.2810,405 shs$9.54 million04/16/2024$4.46$4.33-2.91%$4.55$4.2815,933 shs$9.66 million04/15/2024$4.63$4.46-3.61%$4.63$4.3220,004 shs$9.95 million04/12/2024$4.78$4.60-3.77%$4.97$4.5418,602 shs$10.26 million04/11/2024$5.13$4.78-6.82%$5.13$4.6827,784 shs$10.65 million04/10/2024$5.23$5.13-1.91%$5.69$4.8131,136 shs$11.43 million04/09/2024$5.05$5.23+3.56%$5.29$5.0222,132 shs$11.66 million04/08/2024$5.20$5.05-2.88%$5.34$5.0051,764 shs$11.26 million04/05/2024$5.30$5.20-1.89%$5.50$4.9639,756 shs$11.60 million04/04/2024$5.25$5.30+0.95%$5.31$5.0514,302 shs$11.82 million04/03/2024$5.45$5.25-3.67%$5.63$5.0946,552 shs$11.71 million04/02/2024$5.67$5.45-3.88%$5.70$5.1828,638 shs$12.15 million04/01/2024$5.91$5.67-4.06%$6.09$5.6726,986 shs$12.64 million03/29/2024$5.91$5.91$6.23$5.1878,010 shs$13.18 million03/28/2024$5.54$5.91+6.68%$6.23$5.1877,998 shs$13.18 million03/27/2024$4.68$5.54+18.38%$5.69$4.7589,236 shs$12.35 million03/26/2024$5.25$4.68-10.86%$4.99$4.3491,056 shs$10.44 million03/25/2024$5.70$5.25-7.97%$6.00$4.65915,017 shs$11.70 million03/22/2024$6.63$5.70-13.96%$6.24$5.3097,562 shs$190.59 million03/21/2024$6.31$6.63+5.09%$7.34$6.1144,320 shs$14.77 millionBiden to Drop BOMBSHELL June 13th? (Ad)Biden’s days are numbered! According to a former CIA and Pentagon insider… He’s about to drop out of the presidential race on June 13th!Click here now to see his shocking evidence.03/20/2024$7.86$6.31-19.70%$7.80$6.0064,901 shs$14.05 million03/19/2024$8.25$7.86-4.76%$8.85$7.865,974 shs$17.50 million03/18/2024$7.42$8.25+11.22%$8.55$8.257,085 shs$18.38 million03/15/2024$8.03$7.42-7.67%$8.40$7.208,272 shs$16.52 million03/14/2024$8.41$8.03-4.43%$8.70$7.3512,932 shs$17.89 million03/13/2024$8.42$8.41-0.12%$8.70$8.402,698 shs$18.72 million03/12/2024$9.48$8.42-11.22%$9.47$8.4013,008 shs$18.75 million03/11/2024$10.11$9.48-6.25%$10.35$9.302,779 shs$21.12 million03/08/2024$10.05$10.11+0.61%$10.35$9.904,945 shs$22.52 million03/07/2024$10.05$10.05$10.16$9.515,557 shs$22.39 million03/06/2024$10.11$10.05-0.59%$10.20$9.905,196 shs$22.39 million03/05/2024$10.32$10.11-2.03%$10.32$9.907,840 shs$22.52 million03/04/2024$9.17$10.32+12.60%$10.35$9.0218,036 shs$22.99 million03/01/2024$9.44$9.17-2.86%$9.75$8.858,335 shs$20.41 million02/29/2024$9.15$9.44+3.13%$9.50$8.933,849 shs$21.02 million02/28/2024$9.24$9.15-0.99%$9.26$8.706,372 shs$20.38 million02/27/2024$8.84$9.24+4.58%$9.64$8.5512,522 shs$20.58 million02/26/2024$8.10$8.84+9.11%$8.84$8.067,614 shs$19.68 million02/23/2024$7.73$8.10+4.82%$8.10$7.379,545 shs$18.04 million02/22/2024$7.22$7.73+7.05%$7.73$7.353,576 shs$17.21 million02/21/2024$7.50$7.22-3.76%$7.64$7.174,838 shs$16.07 million02/20/2024$7.46$7.50+0.48%$7.74$7.202,697 shs$16.70 million02/19/2024$7.46$7.46$7.80$7.207,167 shs$16.62 million02/16/2024$7.50$7.46-0.50%$7.80$7.207,170 shs$16.62 million02/15/2024$7.65$7.50-1.92%$8.10$7.352,381 shs$16.71 million Related Companies: MIRA Stock Chart AVTX Stock Chart GHSI Stock Chart ELAB Stock Chart ABVC Stock Chart MNPR Stock Chart AEZS Stock Chart AKTX Stock Chart ADXN Stock Chart NCNA Stock Chart Receive MBRX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Moleculin Biotech and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:MBRX) was last updated on 5/16/2024 by MarketBeat.com Staff From Our PartnersHealthcare Takes A Big Step Forward With The Help Of AIThe Bull ReportBiden to Drop BOMBSHELL June 13th?Paradigm PressElon to Transform U.S. Economy? Porter & CompanyCharles Payne Demystifies OptionsUnstoppable ProsperityThe most important AI company you've never heard ofManward PressThe #1 Biotech Stock to Watch in 2024 is Attacking Viruses in a Unique WaySmallcaps DailyElon’s New Device is About to Shock the WorldInvestorPlaceGold ManiaStansberry Research Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Moleculin Biotech, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.